Skip to content

LivaNova LIVN Depreciation

Depreciation at other companies

Stryker logo
StrykerSYK
$120M+14.3%
Abbott logo
AbbottABT
Nordson logo
NordsonNDSN
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's depreciation?
LivaNova (LIVN) reported depreciation of $8.3M in Q1 2026.
How has LivaNova's depreciation changed year-over-year?
LivaNova's depreciation increased by 29.3% year-over-year, from $6.42M to $8.3M.
What is the long-term trend for LivaNova's depreciation?
Over 4 years (2021 to 2025), LivaNova's depreciation has grown at a 3.9% compound annual growth rate (CAGR), from $24.54M to $28.56M.